US-based medical devices company Dexcom Inc has officially opened its new manufacturing facility, also its first offshore manufacturing site outside the US, in Batu Kawan, Penang.
Penang Chief Minister Chow Kon Yeow said the RM 2.83bn strategic investment will bring more than 3,000 jobs to the state, contributing to a workforce set to positively impact the lives of over three million people worldwide.
Dexcom, founded in 1999, is a global leader in continuous glucose monitoring (CGM) technology for individuals living with diabetes.
“The establishment of this new facility highlights Dexcom’s continued commitment to taking control of health through innovative CGM systems”.
“It also reaffirms Penang’s reputation as a global hub for advanced technological industries, reinforcing its position as a preferred destination for high-quality manufacturing and innovation,” the chief minister said in his speech at the opening ceremony.
Penang Development Corporation chief executive officer Datuk Aziz Bakar, InvestPenang CEO Datuk Loo Lee Lian, and Dexcom chief operating officer Jake Leach were also present at the event.
Chow said Penang is on the right path towards becoming the medical technology (medtech) hub of Southeast Asia by leveraging the state’s over 50 years of industry excellence.
